ARG1 and small cell lung carcinoma: After encouraging preclinical results, the efficacy of pegzilarginase, a recombinant human arginase 1 enzyme, has been tested in combination with the PD-1 inhibitor pembrolizumab in SCLC patients, but no results have been released (NCT03371979).